Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zohreh Soltani

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Hypertension Reports|February 1, 2012
Lipid nephrotoxicity: new concept for an old diseaseLeonard Gyebi, Zohreh Soltani, Efrain Reisin
Current Hypertension Reports|January 27, 2015
The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approachesZohreh Soltani, Vaughn Washco, Stephen Morse, et al.
Current Hypertension Reports|April 17, 2013
Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?Zohreh Soltani, Kashaf Rasheed, Daniel R Kapusta, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 20, 2024
Investigating the effect of exposure to monosodium glutamate during pregnancy on development of autism in male rat offspringZohreh Soltani, Marjan Shariatpanahi, Mehdi Aghsami, et al.
Life Sciences|July 28, 2009
Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in ratsPhilip J Ebenezer, Nithya Mariappan, Carrie M Elks, et al.
Nephron. Experimental Nephrology|November 6, 2009
Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker ratsJie Liao, Zohreh Soltani, Philip Ebenezer, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Hypertension Reports|February 1, 2012
Lipid nephrotoxicity: new concept for an old diseaseLeonard Gyebi, Zohreh Soltani, Efrain Reisin
Current Hypertension Reports|January 27, 2015
The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approachesZohreh Soltani, Vaughn Washco, Stephen Morse, et al.
Current Hypertension Reports|April 17, 2013
Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?Zohreh Soltani, Kashaf Rasheed, Daniel R Kapusta, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 20, 2024
Investigating the effect of exposure to monosodium glutamate during pregnancy on development of autism in male rat offspringZohreh Soltani, Marjan Shariatpanahi, Mehdi Aghsami, et al.
Life Sciences|July 28, 2009
Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in ratsPhilip J Ebenezer, Nithya Mariappan, Carrie M Elks, et al.
Nephron. Experimental Nephrology|November 6, 2009
Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker ratsJie Liao, Zohreh Soltani, Philip Ebenezer, et al.
Pageof 1